TY - JOUR T1 - Wearables to monitoring the activities daily living in patients post-hospitalization by COVID-19 JF - European Respiratory Journal JO - Eur Respir J DO - 10.1183/13993003.congress-2021.PA2271 VL - 58 IS - suppl 65 SP - PA2271 AU - Maria Cecília Moraes Frade AU - Thomas Beltrame AU - Daiane Roberta Viana AU - Marcela Maria Carvalho Da Silva AU - Mariana De Oliveira Gois AU - Carina Araujo De Facio AU - Luana Aprecida Gonzaga AU - Juliano Ferreira Arcuri AU - Valéria Amorim Pires Di Lorenzo AU - Aparecida Maria Catai Y1 - 2021/09/05 UR - http://erj.ersjournals.com/content/58/suppl_65/PA2271.abstract N2 - Background: COVID-19 causes a significant number of deaths in the world, and 10% of the infected individuals must be hospitalized. After the period of hospitalization, beyond the already known consequences, the patients suffer later complications of COVID-19, which are not yet totally clear. Thereafter, patients’ follow-up monitoring provides a better understanding of COVID-19 systemic consequences.Aim: To analyze the ventilatory and cardiac responses and the level of activity during activities of daily living (ADL) in post-hospitalization patients.Methods: Eight men were included, 4 with post-COVID-19 (48±12.4 years; 79.4±3.3 kg; 167±7.7 cm) and 4 healthy (49±12.2 years; 78.2±10 kg; 176±9.3 cm). Healthy subjects were assessed before the pandemic started. All of them used the smart t-shirt (®Hexoskin) with embedded sensors (Respiratory, Activity, and ECG) during (6.4±1.2 days, 8.3±1.4 hours/day) in their free ADL. Breath rate (BR), minute ventilation (Ve), tidal volume (Tv), heart rate (HR), hip acceleration (Acc), and hip cadence (Cad) were split by active (Acc>0.05) and inactive period (Acc<0.05g).Results: Patients with COVID-19 presented higher mean values of BR and HR and lower values of Ve, Tv, Acc, and Cad, both periods (Fig1).Conclusion: The wearables could be a global assessment tool to monitoring the consequences of COVID-19 during ADL. Fig 1. Data wearables during ADL.FAPESP: 2018/22818-9;2016/22215-7.FootnotesCite this article as: European Respiratory Journal 2021; 58: Suppl. 65, PA2271.This abstract was presented at the 2021 ERS International Congress, in session “Prediction of exacerbations in patients with COPD”.This is an ERS International Congress abstract. No full-text version is available. Further material to accompany this abstract may be available at www.ers-education.org (ERS member access only). ER -